Tollovid
Commercial- Indications
- COVID-19
Company intelligence / Profile preview
MSDx has developed a proprietary blood test panel for monitoring neurodegeneration in brain diseases. The company’s patented WINDOW INTO THE BRAIN™ technology provides real-time data on disease activity to aid diagnosis and therapeutic monitoring. Initial clinical focus has been on multiple sclerosis with expansion into other neurological disorders planned. The product was at prototype/early launch stage as of the latest available information; no published pivotal clinical trial results found.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MSDx.